Aigen Investment Management’s Amedisys AMED Stock Holding History

Aigen Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,548	Closed	-$233K	–	806
2023 Q2	$233K	Buy	+2,548	New	+$209K	0.03%	576
2023 Q1	–	Sell	-7,189	Closed	-$601K	–	605
2022 Q4	$601K	Buy	+7,189	New	+$648K	0.09%	234
2022 Q1	–	Sell	-2,816	Closed	-$439K	–	536
2021 Q4	$439K	Sell	2,816 -8,994	-76%	-$1.45M	0.03%	672
2021 Q3	$1.76M	Buy	+11,810	New	+$2.46M	0.34%	82
2020 Q3	–	Sell	-5,721	Closed	-$1.14M	–	843
2020 Q2	$1.14M	Buy	+5,721	New	+$1.07M	0.15%	224
2020 Q1	–	Sell	-58	Closed	-$10K	–	1250
2019 Q4	$10K	Buy	+58	New	+$8.63K	﹤0.01%	966

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Aigen Investment Management's AMED Position: Q3 2023 in Review

Aigen Investment Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,548 shares — an estimated $233K sold.

Aigen Investment Management first reported a position in AMED in Q4 2019 and held it in 6 quarters. The position peaked at $1.76M in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

Aigen Investment Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
Aigen Investment Management sold 2,548 Amedisys shares in Q3 2023, an estimated $233K.
Aigen Investment Management first reported a position in Amedisys in Q4 2019 and held it in 6 quarters.
Aigen Investment Management's Amedisys position peaked at $1.76M in Q3 2021.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Aigen Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.